Form 4: HealthEquity EVP Sells Shares for Tax Obligations

Sentiment:

Insider Transaction Report


HealthEquity's EVP, General Counsel, Delano Ladd, disposed of 977 common shares to cover tax withholding obligations at a price of $88.5674 per share.

Summary

  • Delano Ladd, Executive Vice President and General Counsel of HealthEquity, Inc. (HQY), reported a change in beneficial ownership.
  • On October 6, 2025, Mr. Ladd disposed of 977 shares of HealthEquity Common Stock.
  • The shares were disposed of at a price of $88.5674 per share.
  • This transaction was a disposition to the issuer to satisfy tax withholding obligations, indicated by transaction code 'F'.
  • Following this transaction, Mr. Ladd beneficially owns 78,479 shares of HealthEquity Common Stock directly.
  • The transaction was made pursuant to a contract, instruction, or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Sentiment

Score: 5

Explanation: The transaction is a routine disposition of shares to cover tax withholding obligations, not indicative of a change in sentiment towards the company or its future prospects.

Future Outlook

This filing does not contain any forward-looking statements or guidance regarding the company's future performance or outlook.

Industry Context

This is a routine insider transaction for tax purposes and does not provide specific insights into broader industry trends or competitive positioning.

Stakeholder Impact

  • The impact on shareholders is minimal as this is a routine, non-discretionary transaction by an executive to satisfy tax obligations.

Key Dates

DateDescription
10/06/2025Date of transaction (disposition of shares)
10/08/2025Date the Statement of Changes in Beneficial Ownership (Form 4) was signed and filed

Recommendation

hold

The reported transaction is a routine disposition of shares by an executive to satisfy tax withholding obligations, which is a common practice and does not reflect a change in the executive's or the company's fundamental outlook. It is not indicative of a strategic shift or a lack of confidence in the company's future performance, therefore, it does not warrant a change in investment recommendation.

Keywords

HealthEquity, HQY, Insider Transaction, Form 4, Delano Ladd, Stock Sale, Executive Compensation, Tax Withholding, Rule 10b5-1

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.